Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : The Trump Presidency -- Ignore unavailable to you. Want to Upgrade?

To: Thomas M. who wrote (235887)	5/11/2022 12:10:26 PM
From: i-node	1 Recommendation Recommended By Thomas M. Read Replies (1) \| Respond to of 356169

I cannot understand why every person who contracts Covid doesn't get both HCQ and IVM, along with typical standard-of-care treatments like Dexamethasone, Vits C&D, Zinc, and anything else that is thought to help with zero downside, which is the case with every one of these medications. Particularly, if one has elevated risk factors like age, weight, and other comorbidities. Why would you not do that, even if you thought HCQ and IVM don't do any good? They certainly do no harm. People who get on these drugs as early treatment do better than those who don't, we know that.